GlassScriptPhysician profile
Shariq Afridi
NPI 1467436170
$1,675.99
in general payments reported to CMS, 2019-2025
16 companies · $88.21 in 2025
The $88.21 reported for 2025 was less than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $125 · 2020: $14.75 · 2021: $199 · 2022: $470 · 2023: $399 · 2024: $380 · 2025: $88.21.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $852 · Education: $16.11.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $851.79 |
| Education | $16.11 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Takeda Pharmaceuticals U.S.A., INC. | $564.38 | 2019-2024 | Entyvio |
| Pfizer INC. | $309.00 | 2023-2025 | |
| Nestle Healthcare Nutrition INC. | $141.63 | 2022-2023 | |
| Amgen INC. | $99.14 | 2023 | Amjevita, Avsola |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $97.88 | 2021-2022 | |
| Celgene Corporation | $79.45 | 2021-2022 | |
| Aimmune Therapeutics, INC. | $78.74 | 2024-2025 | Zenpep |
| Medtronic, INC. | $70.32 | 2021-2022 | |
| Janssen Biotech, INC. | $58.61 | 2021-2022 | |
| Daiichi Sankyo INC. | $41.03 | 2019-2024 | Injectafer |
| Boston Scientific Corporation | $37.33 | 2021-2024 | Compliance Endokit |
| Ethicon US, LLC | $32.48 | 2021 | |
| Abbvie INC. | $29.00 | 2024 | |
| Gilead Sciences, INC. | $13.44 | 2024 | |
| Cumberland Pharmaceuticals, INC. | $12.17 | 2022 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Qol Medical, LLC | $11.39 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Shariq Afridi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.